BALB/c mice were immunized with Escherichia coli L -asparaginase and tested for the presence of hemagglutination antibody (HA) to the enzyme. Mice were then grouped according to whether they were immune to L-asparaginase (HA titer, >4) or were non-HA responders (negative HA titer). In vivo antitumor activity of L-asparaginase against P-1798 (an L-asparaginase-sensitive lymphoma) was tested in both groups, as well as in control mice (never before exposed to L-asparaginase). L-Asparaginase was inactive against the tumor in immune mice but was equally active in non-HA responders and control animals. Another experiment compared L-asparaginase derived from E. coli with enzyme derived from Erwinia carotovora (which does not cross-react immunologically with E. coli L-asparaginase). Mice immune to E. coli L-asparaginase received about the same benefit from the antitumor activity of E. carotovora L-asparaginase as did control mice. In separate studies, blood samples from immune, non-HA responder, and control mice were tested by in vitro assays for levels of L-asparaginase and L-asparagine at various time intervals up to 120 hr following a single i.v. injection of L-asparaginase. Most immune mice cleared the plasma of enzyme 30 min after injection and consequently had a rapid return to the circulation of L-asparagine. In non-HA responders and control animals, L-asparaginase was detectable for over 48 hr after injection, and L-asparagine remained absent from the circulation. These studies relate the presence of humoral antibody to L-asparaginase with loss of antitumor and enzymatic activity and suggest that, in immunized animals without detectable HA, the antitumor and enzymatic activity of L-asparaginase is intact.
|Number of pages||6|
|State||Published - 1 Feb 1973|